31
Participants
Start Date
December 2, 2020
Primary Completion Date
May 21, 2022
Study Completion Date
May 17, 2023
Bis-Choline Tetrathiomolybdate
Participants will be initiated at 15 milligrams once daily, then the dose will be increased to 30 milligrams once daily at Week 6.
Research Site, Grafton
Research Site, Århus N
Research Site, Valencia
Research Site, Ann Arbor
Research Site, Dallas
Research Site, Sacramento
Research Site, Moscow
Research Site, Singapore
Research Site, Saint Petersburg
Research Site, Toronto
Research Site, Barcelona
Research Site, London
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY